BBLG
Price:
$1.46
Market Cap:
$2.62M
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialtie...[Read more]
Industry
Medical - Devices
IPO Date
2021-10-13
Stock Exchange
NASDAQ
Ticker
BBLG
According to Bone Biologics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -1.24. This represents a change of 28.58% compared to the average of -0.96 of the last 4 quarters.
The mean historical PE Ratio of Bone Biologics Corporation over the last ten years is -21.94. The current -1.24 PE Ratio has changed 465.18% with respect to the historical average. Over the past ten years (40 quarters), BBLG's PE Ratio was at its highest in in the December 2018 quarter at 534.73. The PE Ratio was at its lowest in in the June 2016 quarter at -6375.58.
Average
-21.94
Median
-1.11
Minimum
-92.92
Maximum
-0.13
Discovering the peaks and valleys of Bone Biologics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.64%
Maximum Annual PE Ratio = -0.13
Minimum Annual Increase = -92.86%
Minimum Annual PE Ratio = -92.92
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.55 | -53.14% |
| 2024 | -1.17 | 46.44% |
| 2023 | -0.80 | -83.57% |
| 2022 | -4.85 | -92.86% |
| 2021 | -67.92 | -26.90% |
| 2020 | -92.92 | 87.70% |
| 2019 | -49.50 | 4.64% |
| 2018 | -1.04 | 104.19% |
| 2017 | -0.51 | 283.33% |
| 2016 | -0.13 | -28.99% |
The current PE Ratio of Bone Biologics Corporation (BBLG) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.84
5-year avg
-15.06
10-year avg
-21.94
Bone Biologics Corporation’s PE Ratio is less than HeartSciences Inc. (-0.37), less than Venus Concept Inc. (-0.01), less than NanoVibronix, Inc. (-0.00), less than DIH Holding US, Inc. (-0.00), greater than Corvex, Inc. (-2.99), less than ENDRA Life Sciences Inc. (-0.58), less than GlucoTrack, Inc. (-0.06), less than Catheter Precision, Inc. (-0.12), less than InMed Pharmaceuticals Inc. (-0.00), less than Biodexa Pharmaceuticals Plc (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.37 | $3.99M | |
| -0.01 | $578.19K | |
| -0.00 | $1.51M | |
| -0.00 | $3.14K | |
| -2.99 | $17.09M | |
| -0.58 | $3.58M | |
| -0.06 | $209.11K | |
| -0.12 | $907.60K | |
| -0.00 | $2.70M | |
| -0.00 | $2.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Biologics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bone Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bone Biologics Corporation's PE Ratio?
How is the PE Ratio calculated for Bone Biologics Corporation (BBLG)?
What is the highest PE Ratio for Bone Biologics Corporation (BBLG)?
What is the 3-year average PE Ratio for Bone Biologics Corporation (BBLG)?
What is the 5-year average PE Ratio for Bone Biologics Corporation (BBLG)?
How does the current PE Ratio for Bone Biologics Corporation (BBLG) compare to its historical average?